Trials / Unknown
UnknownNCT06119880
The Effect of PERT on Patients Undergoing Pancreaticoduodenectomy
The Effect of PERT on Postoperative Complications and Physiological Status in Patients Undergoing Pancreaticoduodenectomy
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A comprehensive perioperative nutrition management plan for pancreaticoduodenectomy, primarily based on pancreatic enzyme replacement therapy (PERT). A prospective randomized controlled study was conducted to comprehensively analyze the perioperative nutritional status of patients undergoing pancreaticoduodenectomy, with the aim of exploring: 1. The effect of PERT on postoperative complications and physiological status after pancreaticoduodenectomy; 2. The efficacy of PERT treatment on clinical symptoms, nutritional indicators, and quality of life (QOL) related to pancreatic exocrine dysfunction (PEI) after pancreaticoduodenectomy; 3. The personalized full process nutrition management strategies based on risk factor stratification.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pancreatin Enteric-coated Capsules | pancreatic enzyme replacement therapy |
| OTHER | Routine treatment plan | Routine treatment plan without PERT |
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2024-12-31
- Completion
- 2025-12-31
- First posted
- 2023-11-07
- Last updated
- 2023-11-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06119880. Inclusion in this directory is not an endorsement.